Literature DB >> 9337564

Epidemiology of gastric cancer and perspectives for prevention.

N Muñoz1, S Franceschi.   

Abstract

The most recent estimates of the world-wide incidence of cancer indicate that gastric cancer was in 1990 the second most frequent cancer in the world (after lung cancer), with about 900000 new cases diagnosed every year. Steady declines in the rates have been observed everywhere in the last few decades, but the absolute number of new cases per year is increasing mainly because of ageing of the population. The exact causes of the decline of gastric cancer are not well understood, but must include improvements in diet, food storage (e.g., refrigeration) and, possibly, the decline of Helicobacter pylori infection. Dietary modifications and, possibly, vitamin supplements remain one of the most important tool for the prevention of gastric cancer. Control of H. pylori infection, by means of eradication or immunization, is also likely to offer great potential for the prevention of this important malignancy.

Entities:  

Mesh:

Year:  1997        PMID: 9337564     DOI: 10.1590/s0036-36341997000400010

Source DB:  PubMed          Journal:  Salud Publica Mex        ISSN: 0036-3634


  19 in total

1.  The functional BRCA1 rs799917 genetic polymorphism is associated with gastric cancer risk in a Chinese Han population.

Authors:  Kun Wang; Longfang Xu; Lin Pan; Kesen Xu; Guixia Li
Journal:  Tumour Biol       Date:  2014-09-30

2.  Advanced or metastatic gastric cancer in elderly patients: clinicopathological, prognostic factors and treatments.

Authors:  Z Lu; M Lu; X Zhang; J Li; J Zhou; J Gong; J Gao; J Li; X Zhang; Y Li; L Shen
Journal:  Clin Transl Oncol       Date:  2012-10-02       Impact factor: 3.405

3.  Safety and efficacy of S-1 monotherapy in elderly patients with advanced gastric cancer.

Authors:  Takahiro Tsushima; Shuichi Hironaka; Narikazu Boku; Nozomu Machida; Kentaro Yamazaki; Hirofumi Yasui; Keisei Taku; Akira Fukutomi; Yusuke Onozawa
Journal:  Gastric Cancer       Date:  2010-12-03       Impact factor: 7.370

4.  Comparison of safety and efficacy of S-1 monotherapy and S-1 plus cisplatin therapy in elderly patients with advanced gastric cancer.

Authors:  Takahiro Tsushima; Shuichi Hironaka; Narikazu Boku; Nozomu Machida; Kentaro Yamazaki; Hirofumi Yasui; Akira Fukutomi; Akiko Todaka; Hiroya Taniguchi; Yusuke Onozawa; Keisei Taku
Journal:  Int J Clin Oncol       Date:  2011-10-22       Impact factor: 3.402

5.  MTHFR polymorphisms in gastric cancer and in first-degree relatives of patients with gastric cancer.

Authors:  Valli De Re; R Cannizzaro; V Canzonieri; E Cecchin; L Caggiari; E De Mattia; C Pratesi; P De Paoli; G Toffoli
Journal:  Tumour Biol       Date:  2009-12-18

Review 6.  Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and gastric cancer susceptibility.

Authors:  Lei-Zhou Xia; Yi Liu; Xiao-Zhou Xu; Peng-Cheng Jiang; Gui Ma; Xue-Feng Bu; Yong-Jun Zhang; Feng Yu; Ke-Sen Xu; Hua Li
Journal:  World J Gastroenterol       Date:  2014-08-28       Impact factor: 5.742

7.  p16 promoter hypermethylation: a useful serum marker for early detection of gastric cancer.

Authors:  Mohammad Reza Abbaszadegan; Omeed Moaven; Hamid Reza Sima; Kamran Ghafarzadegan; Azadeh A'rabi; Mohammad Naser Forghani; Hamid-Reza Raziee; Ali Mashhadinejad; Mostafa Jafarzadeh; Ehsan Esmaili-Shandiz; Ezzat Dadkhah
Journal:  World J Gastroenterol       Date:  2008-04-07       Impact factor: 5.742

8.  New perspectives in the treatment of advanced or metastatic gastric cancer.

Authors:  Gerardo Rosati; Domenica Ferrara; Luigi Manzione
Journal:  World J Gastroenterol       Date:  2009-06-14       Impact factor: 5.742

9.  Mechanisms of Cisplatin-Induced Apoptosis and of Cisplatin Sensitivity: Potential of BIN1 to Act as a Potent Predictor of Cisplatin Sensitivity in Gastric Cancer Treatment.

Authors:  Satoshi Tanida; Tsutomu Mizoshita; Keiji Ozeki; Hironobu Tsukamoto; Takeshi Kamiya; Hiromi Kataoka; Daitoku Sakamuro; Takashi Joh
Journal:  Int J Surg Oncol       Date:  2012-06-12

Review 10.  Roles of Nrf2 in Gastric Cancer: Targeting for Therapeutic Strategies.

Authors:  Tahereh Farkhondeh; Ali Mohammad Pourbagher-Shahri; Mohsen Azimi-Nezhad; Fatemeh Forouzanfar; Aranka Brockmueller; Milad Ashrafizadeh; Marjan Talebi; Mehdi Shakibaei; Saeed Samarghandian
Journal:  Molecules       Date:  2021-05-25       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.